Published in TB and Outbreaks Week, September 13th, 1999
The molecular prediction of isoniazid (INH) resistance in Mycobacterium tuberculosis is hampered by the need for specialized equipment, expertise, high costs, a limited range of detectable mutations, or several of these factors.
The rationale for the study, conducted by H. Rinder and colleagues from Germany's University of Munich, was to find a practical alternative to and to demonstrate generally valid problems with identifying INH resistance ("Culture-Independent Prediction of Isoniazid Resistance in Mycobacterium tuberculosis by katG Gene Analysis...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.